MDxHealth (MDXH) is trading up at $0.60 (+4.55%), as of the latest quote. It operates in the Health Care sector.
| FY2019Dec 2019 | FY2020Dec 2020 | FY2021Dec 2021 | FY2022Dec 2022 | FY2023Dec 2023 | FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | $11.8M | $18.5M | $22.2M | $37.1M | $70.2M | $90.0M | $107.9M |
| Growth (year over year) | — | +56.6% | +20.5% | +66.6% | +89.4% | +28.3% | +19.8% |
| Gross profit | $30.0K | $8.04M | $10.6M | $19.2M | $43.9M | $55.1M | $69.6M |
| Gross margin | 0.3% | 43.6% | 47.5% | 51.9% | 62.6% | 61.2% | 64.5% |
| Operating income | −$43.2M | −$27.1M | −$26.8M | −$37.9M | −$27.3M | −$24.7M | −$14.4M |
| Operating margin | −366.3% | −146.9% | −120.7% | −102.3% | −38.9% | −27.5% | −13.4% |
| Net income | −$43.1M | −$28.7M | −$29.0M | −$44.0M | −$43.1M | −$38.1M | −$33.5M |
| Net margin | −365.7% | −155.3% | −130.4% | −118.9% | −61.4% | −42.3% | −31.1% |
| EPS (diluted) | −$6.90 | $3.40 | $2.38 | −$2.78 | −$1.66 | −$1.16 | −$0.67 |
| Balance sheet | |||||||
| Cash and equivalents | — | $16.0M | $58.5M | $15.5M | $22.4M | $46.8M | $29.0M |
| Total assets | — | $31.9M | $75.1M | $119.1M | $129.1M | $157.3M | $148.0M |
| Total liabilities | — | $26.0M | $28.2M | $109.8M | $121.9M | $142.5M | $160.0M |
| Shareholders' equity | $19.7M | $5.85M | $46.9M | $9.31M | $7.21M | $14.8M | −$12.1M |
| Cash flow | |||||||
| Operating cash flow | −$22.3M | −$20.2M | −$22.5M | −$34.1M | −$21.5M | −$18.5M | −$2.19M |
| Capital expenditure | $73.0K | $537.0K | $896.0K | $2.79M | $2.75M | $1.19M | $1.16M |
| Free cash flow | −$22.4M | −$20.8M | −$23.4M | −$36.9M | −$24.2M | −$19.7M | −$3.35M |
From MDxHealth's 20-F filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Per-share figures are per ordinary share, which is not always the share traded in the US: an ADS can stand for several, or for part of one. Filings on SEC EDGAR →
No recent news mentioning MDxHealth in our feed yet.